Cisplatin + gemcitabine in non-small cell lung cancer (NSCLC). A phase I dose escalation study
Keyword(s):
Phase I
◽
Results of a phase I dose escalation study in the treatment of inoperable non-small cell lung cancer
2003 ◽
Vol 57
(2)
◽
pp. S417-S418
◽
Keyword(s):
Phase I
◽